Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,310
+40 (0.30%)
At close: Aug 14, 2025, 3:30 PM KST

Daewon Pharmaceutical Market Cap

Daewon Pharmaceutical has a market cap or net worth of 285.28 billion as of August 15, 2025. Its market cap has decreased by -27.76% in one year.

Market Cap
285.28B
Enterprise Value
418.76B
Revenue
597.69B
Ranking
n/a
PE Ratio
24.79
Stock Price
13,310.00

Market Cap Chart

Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 285.28B, an increase of 1,479.62%. That is a compound annual growth rate of 11.94%.

History

DateMarket Cap% Change
Aug 14, 2025285.28B-6.60%
Dec 30, 2024305.43B-7.98%
Dec 28, 2023331.93B-15.58%
Dec 29, 2022393.20B14.64%
Dec 30, 2021343.00B-9.91%
Dec 30, 2020380.71B13.65%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 73.52T
Celltrion 38.58T
ALTEOGEN 23.35T
Yuhan 8,561.74B
Peptron 8,235.61B
SK Biopharmaceuticals 7,878.31B
PharmaResearch 7,106.52B
LigaChem Biosciences 5,666.20B
Market Cap Rankings